Le Lézard
Classified in: Oil industry, Environment, Business, Covid-19 virus
Subject: SVY

How to Build Back a Low-Carbon Economy Globally: RMI Stimulus Series


BOULDER, Colo., July 1, 2020 /CNW/ -- Rocky Mountain Institute (RMI) has produced six reports for its Green Stimulus and Recovery series to guide national responses to the economic downturn caused by COVID-19. The series presents guidance for stimulus and recovery investment that can help countries build back better and advance low-carbon economies to deliver a cleaner, healthier, more just, and more resilient future.

The six reports introduce core principles of green stimulus and recovery and present country- and region-specific recommendations for investments and policy actions specific to the United States, China, India, Sub-Saharan Africa, and the Caribbean.

"Stimulus and recovery investments will be vital to our collective rebuilding," said RMI CEO Jules Kortenhorst. "If these investments are strategically targeted, they can help us simultaneously address this current crisis and the climate crisis."

The six reports in the Green Stimulus and Recovery Series are:

Download the reports: https://rmi.org/stimulus-white-papers

Media Inquiries please contact:
Nick Steel, Media Relations Manager, T: +1 347-574-0887, E: [email protected]

Rocky Mountain Institute (RMI)
RMI transforms global energy use to create a clean, prosperous, and secure low-carbon future.

For more information, visit www.rmi.org or follow us on Twitter @RockyMtnInst.

SOURCE Rocky Mountain Institute


These press releases may also interest you

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...



News published on and distributed by: